Abnormally low plasma concentrations of thyroid hormones during sepsis often occur in the absence of thyroidal illness; however, the mechanisms involved in the "euthyroid sick syndrome" remain poorly understood. Here, we describe a previously unrecognized interaction between the thyroid hormone thyroxine (T 4 ) and the proinflammatory cytokine macrophage migration inhibitory factor (MIF), together with its clinical relevance in sepsis. We found that in both patients with severe sepsis, and our rodent model, low plasma T 4 concentrations were inversely correlated with plasma MIF concentrations. The MIF molecule contains a hydrophobic pocket that is important for many of its proinflammatory activities. Binding of L-T 4 (or its hormonally inert isomer D-T 4 ) significantly, and dose-dependently, inhibited the catalytic activity of this pocket. Moreover, administration of exogenous D-T 4 significantly improved survival in mice with severe sepsis. To examine the specificity of the MIF∶T 4 interaction, wild-type and MIF knockout mice were subjected to the carrageenan-air pouch model of inflammation and then treated with D-T 4 or vehicle. D-T 4 significantly inhibited leukocyte infiltration in wild-type mice but not in MIF knockout mice, providing evidence that in vivo T 4 may influence MIF-mediated inflammatory responses via inhibition of its hydrophobic proinflammatory pocket. These findings demonstrate a new physiological role for T 4 as a natural inhibitor of MIF proinflammatory activity. The data may also, in part, explain the low plasma T 4 concentrations in critically ill, euthyroid patients and suggest that targeting the imbalance between MIF and T 4 may be beneficial in improving outcome from sepsis. S epsis is a critical illness with an important inflammatory component that occurs in millions of individuals each year and results in high mortality and morbidity. Low circulating thyroid hormone levels are common in critically ill patients with severe infections and sepsis. This phenomenon of low plasma thyroid hormone levels, occurring in the absence of thyroid illness, is often referred to as "euthyroid sick syndrome." Approximately 60% of critically ill patients have abnormally low plasma T 4 levels, with the lowest levels being observed in patients with sepsis. These low thyroid hormone levels are good indicators of disease severity and predictors of mortality (1, 2). Although the etiology of the euthyroid sick syndrome has been linked to stress responses, impaired tissue function, and altered peripheral thyroid hormone metabolism during sepsis (2-4), the mechanisms involved in its pathophysiology remain poorly understood.
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity November 29, 2010) Abnormally low plasma concentrations of thyroid hormones during sepsis often occur in the absence of thyroidal illness; however, the mechanisms involved in the "euthyroid sick syndrome" remain poorly understood. Here, we describe a previously unrecognized interaction between the thyroid hormone thyroxine (T 4 ) and the proinflammatory cytokine macrophage migration inhibitory factor (MIF), together with its clinical relevance in sepsis. We found that in both patients with severe sepsis, and our rodent model, low plasma T 4 concentrations were inversely correlated with plasma MIF concentrations. The MIF molecule contains a hydrophobic pocket that is important for many of its proinflammatory activities. Binding of L-T 4 (or its hormonally inert isomer D-T 4 ) significantly, and dose-dependently, inhibited the catalytic activity of this pocket. Moreover, administration of exogenous D-T 4 significantly improved survival in mice with severe sepsis. To examine the specificity of the MIF∶T 4 interaction, wild-type and MIF knockout mice were subjected to the carrageenan-air pouch model of inflammation and then treated with D-T 4 or vehicle. D-T 4 significantly inhibited leukocyte infiltration in wild-type mice but not in MIF knockout mice, providing evidence that in vivo T 4 may influence MIF-mediated inflammatory responses via inhibition of its hydrophobic proinflammatory pocket. These findings demonstrate a new physiological role for T 4 as a natural inhibitor of MIF proinflammatory activity. The data may also, in part, explain the low plasma T 4 concentrations in critically ill, euthyroid patients and suggest that targeting the imbalance between MIF and T 4 may be beneficial in improving outcome from sepsis. S epsis is a critical illness with an important inflammatory component that occurs in millions of individuals each year and results in high mortality and morbidity. Low circulating thyroid hormone levels are common in critically ill patients with severe infections and sepsis. This phenomenon of low plasma thyroid hormone levels, occurring in the absence of thyroid illness, is often referred to as "euthyroid sick syndrome." Approximately 60% of critically ill patients have abnormally low plasma T 4 levels, with the lowest levels being observed in patients with sepsis. These low thyroid hormone levels are good indicators of disease severity and predictors of mortality (1, 2) . Although the etiology of the euthyroid sick syndrome has been linked to stress responses, impaired tissue function, and altered peripheral thyroid hormone metabolism during sepsis (2-4), the mechanisms involved in its pathophysiology remain poorly understood.
Migration inhibitory factor (MIF) is a proinflammatory cytokine that plays a critical role in the pathogenesis of sepsis (5-7). Plasma MIF levels are significantly elevated in nonsurvivors, compared with survivors, of severe sepsis (8) , and administration of antibodies against MIF improves survival in experimental sepsis (5) . During sepsis, plasma MIF levels can be higher than 180 ng∕mL (6, 9) , and the increased accumulation of MIF can have a profound effect on organ function (10) (11) (12) (13) (14) and mortality (6, 8, 15, 16) . MIF proinflammatory activity is mediated through signal transduction initiated by interaction between the MIF molecule and the major histocompatibility complex, class-II invariant chain, CD74 (17, 18) . Three-dimensional X-ray crystallography demonstrates that the MIF molecule is homotrimeric with a hydrophobic pocket formed between each adjacent subunit (19, 20) . The hydrophobic pocket of MIF likely plays an important role, as compounds [e.g., (S;R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1)] that bind this region decrease downstream MIF signaling, MIF biological activities, and MIF-associated clinical outcomes (11, 21, 22) . Despite its importance in the pathogenesis of sepsis and other diseases, many of the endogenous mechanisms regulating MIF activity remain unclear.
We herein identify T 4 as a potential endogenous inhibitor of the MIF proinflammatory activities involved in sepsis and thus indicate a previously unrecognized clinically relevant interaction between these two molecules in critically ill patients that can be exploited in future therapeutic approaches for the treatment of sepsis.
Results and Discussion T 4 and MIF Inversely Correlate in Sepsis. We first simultaneously determined T 4 and MIF levels in severe sepsis by analyzing blood samples (n ¼ 26) collected from patients in the medical intensive care unit within the first 72 h following diagnosis of sepsis. Plasma free-T 4 levels (within the range 0.21-1.00 ng∕dL) were significantly and inversely correlated with plasma MIF levels (within the range 200-8659 pg∕mL) with a correlation coefficient of −0.71, (p ¼ 0.0001) (Fig. 1A) . Consistent with these human data, plasma free-T 4 levels decreased and plasma MIF levels increased within hours after the onset of severe sepsis in rats induced by cecal ligation and puncture (CLP) (Fig. 1B) . These results indicate that plasma T 4 and MIF levels are inversely correlated during severe sepsis.
Molecular Modeling of MIF: T 4 Interaction. The intriguing inverse correlation between the MIF and T 4 during sepsis prompted us to further investigate the intimate relationship between these two moieties at a molecular level. Three-dimensional X-ray crystallography has demonstrated that the MIF molecule is homotrimeric with a hydrophobic cavity formed between each adjacent subunit (19, 23) . Previously, we have designed MIF antagonists that target this hydrophobic cavity and have shown that molecules that interact with this site block MIF proinflammatory activity (16, 19, (24) (25) (26) (27) and improve the clinical outcome during severe inflammation (11, 15) . One of these molecules, ISO-1, which has been used by several groups as a small molecule inhibitor of MIF (11, 15, (28) (29) (30) (31) , contains a hydroxylated aryl system. The thyroid hormone T 4 also contains a structurally identical hydroxylated aryl system. Therefore, we reasoned that this hydroxylated aryl system may allow the T 4 molecule to occupy the active site of MIF and thus T 4 may be an endogenous MIF ligand. To examine this possibility we modeled the molecular interactions between MIF and T 4 , its hormonally inert dextro-rotary isomer D-T 4 , and the T 4 metabolite triiodothyronine (T 3 ), whose structures are shown in Fig. 2A . Molecular modeling studies suggested that the MIF hydrophobic pocket can accommodate T 4 according to a binding mode where the hydroxylated aryl system occupies the deepest part of the pocket similar to ISO-1 and other known small molecule MIF inhibitors (Fig. 2 B-D) . Based on this hypothesis, the hydroxyl group forms a hydrogen bond with Asn 97, and the aryl moiety occupies a hydrophobic pocket with two side extensions fitting the iodine residues. The distance between one of these iodine molecules and its electron acceptor suggests further I⋯O stabilization. The central aryl ring occupies a region of hydrophobic contact as illustrated by Fig. 2D , whereas one of the iodine moieties is ideally positioned for halogen bonding with the oxygen atom of Ser 63. Finally the polar head can form hydrogen bonds with polar functional groups of residues at the gate of the binding pocket, including Tyr 36 (Fig. 2 C  and D) but also Lys 32 (not illustrated). This binding hypothesis is corroborated by the available structure-activity relationship data, which indicated (i) equal binding affinities for both T 4 isomers, and (ii) a clear difference in affinity between T 3 and T 4 , consistent with a loss of hydrophobic contact and possible loss of halogen bond stabilization. These molecular models and MIF:ISO-1 cocrystal structural data identify T 4 as a potential endogenous ligand for MIF.
T 4 Binding to MIF Inhibits MIF Tautomerase Activity. We next examined the binding efficiency and the ability of T 4 to interfere with the tautomerase activity of the MIF hydrophobic pocket, which also mediates many of MIF's proinflammatory activities (15) . Both T 4 and its dextro-rotatory isomer (dextrothyroxine; D-T 4 ) bind to and inhibit the enzymatic activity of the MIF hydrophobic cavity in a dose-dependent manner with an IC 50 of 15.8 μM (Fig. 3) . We found that T 4 had similar potency in inhibiting MIF tautomerase activity compared with ISO-1 (IC 50 25 μM), the gold standard synthetic inhibitor of MIF. In addition, T 3 , which differs from T 4 in only a single iodine residue, was only a comparatively weak inhibitor of MIF (IC 50 > 100 μM), demonstrating the high specificity of the T 4 ∶MIF interaction. These results reveal that T 4 (both L and D isomers) binds the MIF hydrophobic pocket with high affinity and inhibits its tautomerase enzymatic activity, thus suggesting that like ISO-1 (10), T 4 could inhibit MIF cytokine proinflammatory activities.
T 4 Inhibits MIF Proinflammatory Activity in Vivo. To delineate MIF∶T 4 interactions from possible T 4 hormonal activities, we utilized the hormonally inert isomer D-T 4 in these in vivo studies.
In the widely used model of localized inflammation [carrageenan injection into a dorsal air pouch (32)] we found that D-T 4 administration to male C57BL/6 mice (n ¼ 21 per group) significantly reduced leukocyte accumulation in the pouch. Moreover, D-T 4 inhibited leukocyte recruitment in wild-type mice, but not in MIF-deficient mice, indicating the specificity of T 4 inhibition on MIF-associated inflammation (Fig. 4A) . We next studied effects of exogenous T 4 administration in mice with sepsis induced by (Fig. 4B) . Importantly, this significant survival improvement was achieved when D-T 4 was first administered within a clinically relevant time frame, i.e., 24 h after the onset of sepsis. In additional studies, mice with thyroidectomy and parathyroidectomy (Thx) performed two weeks before CLP-sepsis induction had a decreased overall survival rate and succumbed to lethality faster than non-Thx mice, underscoring the involvement of thyroid hormones in the morbidity of sepsis. This result was first demonstrated in a study done by Moley et al. in which thyroidectomized rats showed decreased whole body oxygen consumption (VO 2 ) and an increased mortality that could be reversed by T 4 administration (33). Likewise, Thx mice given D-T 4 in our study showed vast improvements in mortality rates (Fig. 4C) (p < 0.05), comparable to those of non-Thx mice given D-T 4 , thus indicating the protective effect is not due to effects of D-T 4 on endogenous thyroid hormone levels or unknown feedback mechanisms.
In conclusion, we have provided evidence for an inverse correlation between plasma T 4 and MIF levels during the progression of sepsis and identify T 4 as a potential endogenous antagonist of MIF inflammatory activity. The data suggest that low T 4 and high MIF may be primary effectors in the lethal systemic inflammatory response during severe sepsis as modulation of either (T 4 replacement or MIF antagonism) can improve survival. It is likely that the low plasma free T 4 levels could result from a significant endogenous T 4 fraction binding the hydrophobic pocket within the MIF molecule. However, because MIF production and release are markedly up-regulated during sepsis, this binding may not be sufficient to effectively inhibit MIF proinflammatory activity and prevent an overwhelming inflammatory response. Interestingly, in our study, D-T 4 (the nonphysiological isomer of T 4 ) supplementation was able to prevent the increased mortality rate in a murine sepsis model, indicating that the therapeutic levels of this compound were likely binding and inhibiting the elevated endogenous MIF. Our findings indicate a previously unrecognized clinically relevant interaction between T 4 and MIF, two key molecules in the critically ill patient. This interaction may be vital for sepsis outcome and should generate interest in the development of previously undescribed therapeutic strategies targeting the imbalance between MIF and T 4 in sepsis.
Materials and Methods
Animals. Male Sprague Dawley rats (300-350 g, Taconic), male BALB/c mice (25-28 g, Taconic), and WT or MIF knockout (KO) C57BL/6 were used for in vivo studies. MIF KO mice were backcrossed eight generations onto a C57BL/6 background and bred using homozygous MIF KO animals. The genotype of the MIF locus of all progeny was determined by genomic PCR. Animals were housed in standard conditions (room temperature 22°C with improves survival in thyroidectomized mice subjected to CLP sepsis. Male C57BL/6 mice underwent thyroidectomy and parathyroidectomy as described in Materials and Methods and were then subject to CLP surgery. Mice were administered DMSO vehicle control (solid circles, n ¼ 16) or D-T 4 (solid triangles, n ¼ 17), and survival was then monitored over two weeks. The survival, which was significantly increased in the D-T 4 group, was 13 and 53%, respectively (p < 0.05).
tional Review Board. Heparinised blood (n ¼ 26) was collected, between 12-120 h postdiagnosis of severe sepsis, from patients in the hospital intensive care unit. Blood was centrifuged at 2;000 × g for 10 min and plasma was used for MIF and free T 4 determinations by using enzyme linked immunosorbent assays (R&D Systems and BioQuant, respectively).
Determination of MIF and T 4 in Plasma of Rats with CLP-Induced Sepsis. Peritonitis and severe sepsis was induced in male rats (319 AE 37 g) by CLP as described previously (11) . Animals (n ¼ 5∕group) were euthanized at 6, 20, or 30 h post-CLP and heparinised blood samples collected via cardiac puncture. Blood was also collected from sham operated animals (n ¼ 6) immediately postsurgery. Blood was centrifuged at 2;000 × g for 10 min and plasma was assessed for MIF and free T 4 using enzyme linked immunosorbent assays (Chemicon International and BioQuant, respectively).
Inhibition of the MIF Tautomerase Activity Associated with the Hydrophobic Cavity. MIF tautomerase activity was determined as previously described (25) . Dopachrome Tautomerase Assay: L-Dopachrome methyl ester was prepared at 2.4 mM through oxidation of L-3,4-dihydroxyphenylalanine methyl ester with sodium periodate as previously described (25) . Activity was determined at room temperature by adding dopachrome methyl ester (0.3 mL) to a cuvette containing 50 nM MIF in 50 mM potassium phosphate buffer, pH 6, 0.5 mM EDTA and measuring the decrease in absorbance from 2 to 20 s at 475 nm spectrophotometrically. T4, D-T4, T3, and ISO-1 were dissolved in Me 2 SO at various concentrations and added to the cuvette with the MIF prior to the addition of the dopachrome.
Carrageenan Air Pouch Model and D-T 4 Administration. The carrageenan air pouch model was performed as previously described (32) . Briefly, dorsal air pouches were generated in female C57BL/6 mice and MIF KO mice (C57BL/6) by injecting 5 mL of sterile air s.c. on days 0 and 3. On day 6, mice were given D-T 4 (4 mg∕kg, i.p.) or vehicle and then challenged with an intrapouch injection of 1% carrageenan (1 mL) 15 min later. Animals were euthanized by CO 2 asphyxiation 5 h post carrageenan injection, and cellular infiltrates were collected following the injection of 3 mL of PBS containing 2 mM EDTA. RBC-free cellular infiltrates were counted using a hemocytometer.
D-T 4 Administration in
Mice with CLP-Induced Severe Sepsis. Peritonitis and severe sepsis were induced in male BALB/c mice by CLP as previously described (15) . Mice were administered D-T 4 (4 mg∕kg, n ¼ 17) or vehicle (•, n ¼ 17) intraperitoneally 24 h after CLP. Single doses of D-T 4 or vehicle were administered again on days 2 and 3. Survival was monitored for 7 d.
For some experiments, the animals had undergone thyroid and parathyroid removal approximately 2 wk before undergoing CLP. These mice were supplemented with calcium chloride in the drinking water.
Statistical Analyses. Data are expressed as mean AE SEM. Regression analysis was applied to assess correlations. Significant differences were assessed by using one way analysis of variance (ANOVA) followed by a Student t test. The statistical significance of differences between groups of animals in survival experiments was analyzed by the log-rank test using the all pairwise multiple comparison procedure (Holm-Sidak method). Differences with P < 0.05 were considered statistically significant.
